Used for local nerve block and for spinal anesthesia; pharmacological properties are similar to those of lidocaine.
Features and Benefits
This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is also offered as part of Sigma′s Library of Pharmacologically Active Compounds (LOPAC®1280), a biologically annotated collection of high-quality, ready-to-screen compounds. Click here to learn more.
LOPAC is a registered trademark of Sigma-Aldrich Co. LLC